A clinical stage research and development pharmaceutical company located in Jupiter, Florida. The Company incorporated in Delaware in January 2016. The Company has developed a unique resveratrol platform product targeting treatment of neuro-inflammation.
Lead Underwriter
Dawson James Securities, Inc, Roth Capital Partners, Inc
